MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202547035082 A) filed by Visterra Inc., Waltham, U.S.A., on April 10, for 'treatment of complement mediated diseases and disorders with c3b antibodies.'
Inventor(s) include Viswanathan Karthik; Ramakrishnan Ramki; Adari Hedy; Gao Feng; and Wollacott Andrew.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides among other things anti C3b antibodies with increased specificity and potency and methods of treating C3 glomerulopathy and other complement mediated diseases and disorders using the same."
The patent application was ...